iosr-JPBS   Volume-20 ~ Issue-6 ~ Nov. – Dec. 2025

[1]. Roberts MS, Mohammed Y, Pastore MN, Et Al. Topical And Cutaneous Delivery Using Nanosystems. J Control Release. 2022;341:361-380.
[2]. Grand View Research. Topical Drug Delivery Market Size Report, 2024-2029. Published March 2024. Report ID: GVR-4-68038-956-2.
[3]. U.S. Food And Drug Administration. Topical Drug Products: Bioequivalence And Biowaivers - Guidance For Industry. Published October 2022. FDA-2020-D-1105.
[4]. Zhang L, Lionberger R, Raw A. FDA Office Of Generic Drugs 2024 Annual Report: Topical Drug Product Approvals And Regulatory Science Advances. Clin Pharmacol Ther. 2024;115(4):782-791.
[5]. Raney SG, Franz TJ, Lehman PA, Et Al. Pharmacokinetics-Based Approaches For Bioequivalence Evaluation Of Topical Dermatological Drug Products. Clin Pharmacokinet. 2023;62(3):435-448

[1] C. S. Parenteau, E. C. Lau, I. C. Campbell, And A. Courtney, “Prevalence Of Spine Degeneration Diagnosis By Type, Age, Gender, And Obesity Using Medicare Data,” Sci. Rep., Vol. 11, No. 1, P. 5389, Mar. 2021, Doi: 10.1038/S41598-021-84724-6.
[2] M. Gambacciani, A. Pepe, B. Cappagli, E. Palmieri, And A. R. Genazzani, “The Relative Contributions Of Menopause And Aging To Postmenopausal Reduction In Intervertebral Disk Height,” Climacteric, Vol. 10, No. 4, Pp. 298–305, Jan. 2007, Doi: 10.1080/13697130701457729.
[3] J. C. Iatridis And I. Ap Gwynn, “Mechanisms For Mechanical Damage In The Intervertebral Disc Annulus Fibrosus,” J. Biomech., Vol. 37, No. 8, Pp. 1165–1175, Aug. 2004, Doi: 10.1016/J.Jbiomech.2003.12.026.
[4] P. P. Raj, “Intervertebral Disc: Anatomy‐Physiology‐Pathophysiology‐Treatment,” Pain Pract., Vol. 8, No. 1, Pp. 18–44, Jan. 2008, Doi: 10.1111/J.1533-2500.2007.00171.X.
[5] A. E. Karchevskaya, Y. M. Poluektov, And V. A. Korolishin, “Understanding Intervertebral Disc Degeneration: Background Factors And The Role Of Initial Injury,” Biomedicines, Vol. 11, No. 10, P. 2714, Oct. 2023, Doi: 10.3390/Biomedicines11102714

[1]. Adedapo, A. D. A; Osude, Y. O; Adedapo, A. A,; Moody, J. O; Adeagbo, A. S; Olajide, O. A And Makinde, J. M “Blood Pressure Lowering Effect Of Adenanthera Pavonine Seed Extract On Normotensive Rats”. Records Of Natural Products”3. (2009.) :82-89
[2]. Al-Meshal, .I.A; Tariq, M; Parma, N.S And Ageel, A.M.,. “Anti-Inflammatory Activity Of The Flavonoid Fraction Of Khat (Catha Edulis Forsk)”. Inflammation Research, (1986)17:380
[3]. Amir Montakhab., Abdul Halim Ghazali., Megat Johari., Megat Moh’d Noor. Thalmer Ahmed Mohammed And Badronnisa B.T.Yusuf., “Effects Of Drying And Salt Extraction Of Moringa Oleifera On Its Coagulation Of High Turbid Water”. Journal Of American Sciences, 6 (10), (2010).387-391
[4]. Argal, A And Pathak, A.K. “CNS Activity Of Calotropis Gigantean Roots. Journal Of Ethnopharmacology”, (2006). 106,142-145
[5]. Armando Caceres, Ofyluz Cabrera, Ollfelia Morales, Patricia Mollinedo And Patricia Mendia.. “Pharmacological Properties Of

[1]. « Duthé, G., Fleury, L., Meslé, F., & Väisänen, H. (2024). L’espérance De Vie Humaine Va-T-Elle Continuer À Augmenter? Pour Qui?. Digressions, (8), 172-178. »
[2]. « Bettencourt, P. J., & GBD 2021 Forecasting Collaborators. (2024). Burden Of Disease Scenarios For 204 Countries And Territories, 2022–2050: A Forecasting Analysis For The Global Burden Of Disease Study 2021. The Lancet, 403(10440), 2204-2256. »
[3]. « Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., ... & Amani, R. (2024). Global Burden And Strength Of Evidence For 88 Risk Factors In 204 Countries And 811 Subnational Locations, 1990–2021: A Systematic Analysis For The Global Burden Of Disease Study 2021. The Lancet, 403(10440), 2162-2203. »
[4]. « Troussard, X., Cornet, E., Bardet, V., Couaillac, J. P., Fossat, C., Luce, J. C., ... & Corberand, J. (2014, September). Étude Des Valeurs Normales De L’hémogramme Chez L’adulte: Un Besoin Pour Une Meilleure Interprétation Et Pour L’accréditation Du Laboratoire. In Annales De Biologie Clinique (Vol. 72, No. 5, Pp. 561-581). »
[5]. « Tefferi, A., Hanson, C. A., & Inwards, D. J. (2005, July). How To Interpret And Pursue An Abnormal Complete Blood Cell Count In Adults. In Mayo Clinic Proceedings (Vol. 80, No. 7, Pp. 923-936). Elsevier. »

[1]. Bary, A. D. (1866). Morphology And Physiology Of Fungi, Lichens And Myxomycetes. In Hofmeister's Handbook Of Physiological Botany (Vol. 2, Pp. 1831–1888). Leipzig, Germany.
[2]. Petrini, O. J., & Hirano, S. S. (Eds.). (1991). Microbial Ecology Of Leaves (Pp. 179–197). New York: Springer.
[3]. Azevedo, J. L., Júnior, W. M., Pereira, J. O., & Araújo, W. L. (2000). Endophytic Microorganisms: A Review On Insect Control And Recent Advances On Tropical Plants. Electronic Journal Of Biotechnology, 3, 40–65. Http://Dx.Doi.Org/10.2225/Vol3-Issue1-Fulltext-4
[4]. Card, S. D., Johnson, L. J., Teasdale, S., & Caradus, J. R. (2016). Deciphering Endophyte Behaviour: The Link Between Endophyte Biology And Efficacious Biological Control Agents. FEMS Microbiology Ecology, 92(8), Fiw114.

[1]. Abed, A., Derakhshan, M., Karimi, M., Shirazinia, M., Mahjoubin-Tehran, M., Homayonfal, M., Hamblin, M. R., Mirzaei, S. A., Soleimanpour, H., Dehghani, S., Dehkordi, F. F., & Mirzaei, H. (2022). Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.797804
[2]. Adepu, S., & Ramakrishna, S. (2021). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26(19), 5905. https://doi.org/10.3390/molecules26195905
[3]. Altammar, K. A. (2023). A review on nanoparticles: characteristics, synthesis, applications, and challenges. Frontiers in Microbiology, 14(1155622). https://doi.org/10.3389/fmicb.2023.1155622
[4]. Alven, S., Sendibitiyosi Gandidzanwa, Basabele Ngalo, Olwethu Poswayo, Tatenda Madanhire, Aderibigbe, B. A., & Zenixole Tshentu. (2024). Platinum Group Metals Nanoparticles in Breast Cancer Therapy. Pharmaceutics, 16(9), 1162–1162. https://doi.org/10.3390/pharmaceutics16091162
[5]. Alyami, N. M., Almeer, R., & Alyami, H. M. (2022). Role of green synthesized platinum nanoparticles in cytotoxicity, oxidative stress, and apoptosis of human colon cancer cells (HCT-116). Heliyon, 8(12), e11917. https://doi.org/10.1016/j.heliyon.2022.e11917

[1]. Anto, F., Victor Asoala , Martin Adjuik , Thomas Anyorigiya , Abraham Oduro , James Akazili , Patricia Akweongo, P. A., Bimi, L., & Hodgson, and A. (2013). Water Contact Activities and Prevalence of Schistosomiasis Infection among School-age Children in Communities along an Irrigation Scheme in Rural Northern Ghana. Journal of Bacteriology and Parasitology, 4(4). https://doi.org/10.4172/2155-9597.1000177
[2]. Boelee, E ; Madsen, H. (2006). Irrigation and schistosomiasis in Africa_ Ecological aspects. Colombo, Sri Lanka : International Water management institute. 39p. (IWMI research report99).
[3]. Brown, D.S; T.K.Kristensen, D. S. (1993). A field guide to African freshwater snails: West African species D.S.Danish Bilharziasis.
[4]. Chandiwana, S. ; C. N. (1988). Analysis of the dynamics of transmission of human schistosomiasis in the highveld region of Zimbabwe. A review. Ropical Medicine and Parasitology, 39(3), 187–193.
[5]. Hailegebriel, T., Nibret, E., & Munshea, A. (2020). Prevalence of Schistosoma mansoni and S . haematobium in Snail Intermediate Hosts in Africa : A Systematic Review and Meta-analysis. 2020.

[1]. Mann DL, Greene SJ, Givertz MM, et al. LIFE Investigators. Sacubitril/Valsartan in Advanced Heart Failure with Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. JACC Heart Fail. 2020 Oct;8(10):789-799.
[2]. Cunningham JW, Vaduganathan M, et al. Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure with Preserved Ejection Fraction. JACC Heart Fail. 2020 May;8(5):372-381.
[3]. Tsutsui H, Momomura S, et al. Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study. J Cardiol. 2017 Sep;70(3):225-231.
[4]. Solomon SD, Claggett B, et al. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016 Mar;9(3): e002744.
[5]. Okumura N, Jhund PS, et al; Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circ Heart Fail. 2016 Sep;9(9): e003212.